Related Experiment Video
Updated: May 21, 2026
08:53
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Cell Death & Disease
|June 29, 2012
Summary
BRCA1 loss in breast cancer cells increases insulin-like growth factor-1 (IGF-1) expression, activating the IGF-1 receptor pathway and promoting cell proliferation. Inhibiting this pathway reduces the growth of BRCA1-deficient cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The insulin-like growth factor-1 receptor (IGF-1R) pathway is crucial in mammary gland development and cancer.
- IGF-1 promotes breast cancer cell proliferation and is elevated in BRCA1/2-mutated tumors.
Purpose of the Study:
- To investigate the regulatory role of BRCA1 in IGF-1 expression in human breast cancer cells.
- To elucidate the mechanism by which BRCA1 loss impacts IGF-1 signaling and cell proliferation.
Main Methods:
- BRCA1 knockdown (BRCA1-KD) in MCF7 cells.
- Analysis of IGF-1 mRNA and protein expression.
- Chromatin immunoprecipitation (ChIP) to assess BRCA1 and ERα binding to the IGF-1 promoter.
- Reporter gene assays (Luciferase).
- Cell proliferation assays and pathway inhibition studies.
Main Results:
- BRCA1 knockdown induced IGF-1 mRNA expression in an estrogen receptor α (ERα)-dependent manner.
- BRCA1 and ERα bind to an estrogen-responsive element-like (EREL) site on the IGF-1 promoter.
- BRCA1-KD increased extracellular IGF-1 protein, activating the IGF-1R/PI3K/AKT pathway.
- Inhibition of the IGF-1/IGF-1R/PI3K/AKT pathway reduced proliferation in BRCA1-KD cells.
Conclusions:
- BRCA1 negatively regulates IGF-1 transcription via an EREL site on its promoter.
- Loss of BRCA1 function leads to sustained activation of the IGF-1/PI3K/AKT signaling pathway.
- This pathway activation contributes significantly to increased cell survival and proliferation in BRCA1-deficient breast cancer.
Related Concept Videos
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...